|

Vinblastine Sulfate Clinical Trials

2 actively recruiting trials across 2 locations

Also known as: 29060 LE, 29060-LE, Exal, VINCALEUKOBLASTINE, Velban +2 more

Pipeline

Phase 3: 1Phase 2/3: 1

Top Sponsors

  • National Cancer Institute (NCI)2

Indications

  • Cancer2
  • Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v81
  • Renal Pelvis and Ureter Urothelial Carcinoma1

Birmingham, Alabama1 trial

A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

Children's Hospital of Alabama

Phase 3

Kingman, Arizona1 trial

Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer

Kingman Regional Medical Center

Phase 2/3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.